Dong, S., Wei, C., Wang, X., Yang, X., Shen, W., Li, S., Xu, J., Ma, Y., Bie, L., Yu, W., Li, N. (2025). A retrospective multicenter study on the efficacy and safety of disitamab vedotin monotherapy versus combination with anti-PD-1 immunotherapy in advanced gastric cancer. Scientific Reports. https://doi.org/10.1038/s41598-025-86504-y